PSC occurs in 1 out of 10,000 people, who are mostly male adults between 30 and 60 years old, and it commonly develops in ...

A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...

Multiple myeloma is an incurable plasma cell malignancy despite major therapeutic advances. A recent review by Chinese ...

The Maryland life sciences campus is part of a package deal alongside Human Genome Sciences, which Samsung is acquiring from ...

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply networkAdditional investments planned to expand the site's capacity (currently at 60,000 ...

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceuticals. -- Vir Biotechnology's chronic hepatitis delta ...

A hybrid modeling framework to optimize Chinese hamster ovary cell cultures for monoclonal antibody (mAb) production reduces the number of modeling parameters needed while returning results that ...

Curious about the animals most often used in research? Get to know the top five—like mice, rabbits, and goats—and the roles ...

A new artificial intelligence model could help design antibodies that better protect the body against viruses and disease.

During this unique study, scientists sought to understand if artificial intelligence could be used to predict how the ...

("GenSci"), RTW Investments, LP ("RTW"), and Yarrow Bioscience, Inc. ("Yarrow") today announced an exclusive global ex-China license agreement for GS-098, a clinical-stage, first-in-class, humanized ...